Age verification

Age Verification Required

This website contains research peptides intended for laboratory use by qualified individuals aged 18 and over.

By continuing, you confirm that you are at least 18 years old and agree that all products are for research purposes only.

You must verify your age to access this site. This verification is stored for your current device.

Ipamorelin and the GHRP Family: Current Research
← Back to Blog
Research6 min read

Ipamorelin and the GHRP Family: Current Research

Ipamorelin is a selective growth hormone secretagogue with a favourable research profile. This post explores its mechanism of action and what peer-reviewed studies have found.

Simplex Research Team·February 20, 2025

ipamorelin-growth-hormone-research.

Introduction to GHRPs

Growth Hormone Releasing Peptides (GHRPs) are a class of synthetic peptides that stimulate the release of growth hormone (GH) from the pituitary gland. They act via the ghrelin receptor (GHSR-1a) and represent an active area of research in metabolic, anti-ageing, and regenerative medicine.

Ipamorelin: The Selective GHRP

Ipamorelin is a pentapeptide (Aib-His-D-2-Nal-D-Phe-Lys-NH2) developed as a highly selective GHRP. Its key advantage over earlier GHRPs (GHRP-6, GHRP-2) is its selectivity — it stimulates GH release without significantly affecting cortisol, prolactin, or ACTH levels.

Mechanism of Action

  1. **GHSR-1a binding** — ipamorelin binds and activates the ghrelin receptor in the pituitary
  2. **GH pulse stimulation** — produces a clean, pulsatile GH release mimicking physiological patterns
  3. **Synergy with GHRH** — works synergistically with GHRH analogues (e.g. CJC-1295) to amplify GH output
  4. **No negative feedback suppression** — unlike exogenous GH, does not suppress endogenous production

Research Profile Comparison

PeptideGH ReleaseCortisolProlactinSelectivity
GHRP-6StrongElevatedElevatedLow
GHRP-2Very strongElevatedElevatedLow
HexarelinVery strongElevatedElevatedLow
**Ipamorelin****Moderate****Unchanged****Unchanged****High**

Key Research Findings

Body Composition

Animal studies have demonstrated ipamorelin's effects on:

- Increased lean body mass

- Reduced adiposity

- Improved bone mineral density

Recovery and Repair

Through GH-mediated IGF-1 elevation, ipamorelin research has explored:

- Accelerated wound healing

- Enhanced collagen synthesis

- Improved recovery from musculoskeletal injuries

Metabolic Effects

- Improved insulin sensitivity in GH-deficient models

- Enhanced lipid metabolism

- Increased energy expenditure

Sleep Architecture

Preclinical data suggests ipamorelin may improve slow-wave sleep quality, consistent with the known relationship between GH and sleep.

CJC-1295 + Ipamorelin Combination

The combination of CJC-1295 (a GHRH analogue) with ipamorelin is one of the most researched peptide pairings. CJC-1295 provides sustained GHRH stimulation while ipamorelin adds a selective GHSR pulse, resulting in significantly amplified GH release compared to either peptide alone.

Safety Profile

Ipamorelin's selectivity translates to a clean safety profile in preclinical studies. The absence of cortisol and prolactin elevation differentiates it from earlier-generation GHRPs and makes it a preferred model compound for GH research.

Conclusion

Ipamorelin remains one of the most useful research tools for studying the GH axis. Its high selectivity, predictable pharmacology, and synergy with GHRH analogues make it a cornerstone of growth hormone secretagogue research.

Related Products

- Buy Ipamorelin 10MG

Explore Simplex Peptides

- Browse research peptides for sale

- Read more research articles

External Research Resources

- PubMed research on ipamorelin ghrp

- Peptide research literature on PubMed